Blaine Labs Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Dec 22, 2025
  • 2 Class I recalls
  • Last warning letter 2020
Inspections 8 3 OAI
Recalls 9 2 Class I (22%)
Warning letters 1 Latest May 5, 2020
510(k) clearances 1 Latest Jul 25, 2000

Blaine Labs Inc has 9 FDA recalls (2 Class I), 8 inspections, 1 510(k) clearance and 1 compliance action on record. FDA has issued 1 warning letter to Blaine Labs Inc, the most recent on May 5, 2020.

What these totals cover: FDA records filed under the name "Blaine Labs Inc" and its spelling variant "Blaine Labs".

Latest recall
D-0699-2026 · Class II · Apr 8, 2026
Latest inspection
Dec 22, 2025 · OAI
Latest 510(k)
Jul 25, 2000

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls9 (2 Class I)Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances1Nov 15, 2026File dated Nov 9, 2026Current
Inspections8Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Blaine Labs Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Blaine Labs Inc: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I) 2021: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 1 recall record (1 Class I) 2023: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 8 recall records (1 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600081
202511000
202400000
202311000
202200011
202111000
202000100
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Blaine Labs Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Blaine Labs Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Blaine Labs Inc FDA Warning Letters

1 warning letter on May 5, 2020.

IssuedSubjectIssuing officeClose-out letter
May 5, 2020 · Letter on fda.gov Division of Pharmaceutical Quality Operations IV

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

9 recall records from Jan 25, 2022 to Apr 8, 2026.

NumberClassProductDate
D-0699-2026Class IIRevitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl…Apr 8, 2026
D-0694-2026Class IITRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured…Apr 8, 2026
D-0692-2026Class IRevitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter…Apr 8, 2026
D-0693-2026Class IITRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle…Apr 8, 2026
D-0697-2026Class IITERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL)…Apr 8, 2026
D-0695-2026Class IITERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine…Apr 8, 2026
D-0698-2026Class IIFungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal…Apr 8, 2026
D-0696-2026Class IIvite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine…Apr 8, 2026
D-0668-2022Class IREVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b)…Jan 25, 2022

Recent FDA inspections

8 inspections from Aug 12, 2010 to Dec 22, 2025.

DateSiteProductClassificationFEI
Dec 22, 2025Santa Fe Springs, CADrugsOfficial Action Indicated (OAI)3001744192
Dec 15, 2023Santa Fe Springs, CADrugsOfficial Action Indicated (OAI)3001744192
Aug 24, 2021Santa Fe Springs, CADrugsOfficial Action Indicated (OAI)3001744192
Mar 24, 2016Santa Fe Springs, CADevicesNo Action Indicated (NAI)3001744192
Nov 16, 2015Santa Fe Springs, CADrugsVoluntary Action Indicated (VAI)3001744192
Apr 26, 2013Santa Fe Springs, CADevicesVoluntary Action Indicated (VAI)3001744192
Jul 23, 2012Santa Fe Springs, CADrugsVoluntary Action Indicated (VAI)3001744192
Aug 12, 2010Santa Fe Springs, CADrugsVoluntary Action Indicated (VAI)3001744192
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Blaine Labs Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, May 5, 2020.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3001744192Santa Fe Springs, CA8Dec 22, 2025

Recent 510(k) clearances

1 510(k) clearance on Jul 25, 2000.

K-NumberDeviceDate
K001608BLAINE SCARCARE PATCHJul 25, 2000

Blaine Labs Inc and the FDA: common questions

Has Blaine Labs Inc received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Blaine Labs Inc. The most recent is dated May 5, 2020.

Has Blaine Labs Inc received an FDA Form 483?

FDA has not published a Form 483 for "Blaine Labs Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Blaine Labs Inc?

The most recent FDA inspection on file ended Dec 22, 2025 at Santa Fe Springs, CA and was classified OAI. FDA has 8 inspections of Blaine Labs Inc on file, 3 of them classified OAI (official action indicated).

Has Blaine Labs Inc had an FDA recall?

Yes. Blaine Labs Inc has 9 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Apr 8, 2026.

Need more than this page shows? Ask about Blaine Labs Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.